What is your approach to managing HIV-related Hard Belly* in patients with lipodystrophy when a patient first presents with this condition?
On average, how many HIV patients do you see per month?
What is your office setting?
How important is managing HIV-related Hard Belly* in patients with lipodystrophy?
How would you like to receive more information about EGRIFTA SV™?
Please select at least one option. If you do not select an option, we’ll send you more information through the mail.
*Also known as excess abdominal fat